Sales and Marketing

Showing 15 posts of 11527 posts found.

India’s clinical trials hit by ethical concerns

October 12, 2012 Manufacturing and Production, Research and Development, Sales and Marketing India, Lunt, clinical trials

India’s clinical trials industry is facing a crisis because of growing concerns about unethical or illegal practices in the sector. …

BIA welcomes appointment of UK MEP

October 12, 2012 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing BIA, Glenis Willmott

The BioIndustry Association (BIA) has said it welcomes the appointment of UK MEP Glenis Willmott as the rapporteur for the …

Publicis Life Brands Medicus appoints managing director

October 12, 2012 Business Services, Medical Communications, Research and Development, Sales and Marketing Adrian Sansone, publicis

The Publicis Healthcare Communications Group (PHCG) has appointed Adrian Sansone as managing director, Publicis Life Brands Medicus (PLBM). PLBM is …

GSK signs TB vaccine agreement

October 11, 2012 Research and Development, Sales and Marketing Aeras, GSK, TB

GlaxoSmithKline Vaccines has signed a deal with US not-for-profit biotech Aeras to develop a new vaccine which will treat tuberculosis …

Government showcases dementia research

October 11, 2012 Sales and Marketing Cameron, DH, UK, dementia

The government is attempting to encourage international organisations to help the UK’s efforts to find better treatments for dementia. An …

Hunt prioritises elderly and cancer

October 10, 2012 Sales and Marketing

Health secretary Jeremy Hunt yesterday put the care of the elderly at the centre of his vision for public health …

AZ licences renal disease compound

October 9, 2012 Research and Development, Sales and Marketing Ardelyx, AstraZeneca, NHE3

AstraZeneca has signed an agreement giving it worldwide exclusive rights to California-based Ardelyx’s NHE3 inhibitor programme targeting liver and kidney …

Scotland ‘no’ to Avastin

October 9, 2012 Sales and Marketing NICE, Roche, Scotland, avastin

Roche has slammed the Scottish Medicines Consortium (SMC)’s decision not to recommend Avastin for women with advanced ovarian cancer in …

Digital Pharma: what should we talk about?

October 8, 2012 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Boehringer, Facebook, Pfizer, digital pharma, social media, twiiter

The received wisdom today among the ‘digirati’ is that the pharmaceutical industry must join in the online conversation, and to …

Takeda to buy LigoCyte for $60 million

October 8, 2012 Sales and Marketing LigoCyte, Takeda, norovirus

Takeda Pharmaceutical Company is to pay $60 million upfront to buy private US biopharma firm LigoCyte Pharmaceuticals in the next …

Sanofi’s Zaltrap data published

October 8, 2012 Research and Development, Sales and Marketing Erbitux, Sanofi, Stivarga, Zaltrap, avastin

Detailed data from the Phase III trial of Sanofi’s newly-licenced anti-VEGF cancer drug Zaltrap, co-marketed with Regeneron, has been published. …

Chiltern announces new chief executive

October 8, 2012 Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Jim Esinhart, chiltern

Contract research organisation Chiltern International has announced a successor to chief executive Glenn Kerkhof, who is stepping down to be …

NICE does Lucentis U-turn

October 5, 2012 Sales and Marketing Lucentis, NICE, Novartis, Roche, avastin

NICE has done a U-turn over its previous verdict on Novartis’ Lucentis, now recommending the drug in draft guidance to …

NHS under fire for ‘misdiagnosis’

October 5, 2012 Sales and Marketing BHIVA, HIV, NHS

Patients with HIV infections are going unnoticed by the NHS while those with rare diseases are often being misdiagnosed. These …

Appointments and moves at the BIA

October 5, 2012 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing BIA, BioIndustry Association

The BioIndustry Association (BIA) has appointed Harren Jhoti and Will West to its Board of directors at its Annual General …
The Gateway to Local Adoption Series

Latest content